Astrazeneca Pharma India Ltd.

Business: Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids;

Incorporated: 1979

Chairman: Narayan K Seshadri

Managing Director: Gagandeep Singh Bedi

Group: Astrazeneca Pharma India - MNC

Listing: NSE: ASTRAZEN, BSE: 506820

Headquarters: Bengaluru, Karnataka

Website: www.astrazenecaindia.com

Market cap: R 8,538.88 Cr

Revenue (TTM): R 831.81 Cr

Earnings (TTM): R 72.21 Cr

Cash: R 252.52 Cr

Total Debt: R 0.00 Cr

Promoters' ownership: 75.00%

Liquidity: High

52 Week range: R 1,632.55 - 3,700.00

Face value: R2.00

Shares outstanding: 2,50,00,000

10 Years Aggregate:

• CFO: 296.96 Cr
• EBITDA: 332.84 Cr
• Net Profit: 150.89 Cr